Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Amyloid β

Amyloid β denotes peptides of 36–43 amino acids result from the APP (amyloid precursor protein) and are involved in Alzheimer's disease as the main component of the amyloid plaques.

Items 1-10 of 26

Page
per page
  1. Amyloid Beta-Peptide (12-28) (human)
    A1123 Amyloid Beta-Peptide (12-28) (human)
    Summary: sequence H2N-VHHQKLVFFAEDVGSNK-OH
      ≥195.5 mg/mL
  2. Amyloid Beta-Peptide (1-40) (human)
    A1124 Amyloid Beta-Peptide (1-40) (human)
     1 Citation
    Summary: Amyloid precursor protein
      insoluble in EtOH; ≥23.8 mg/mL
  3. Beta-Amyloid (1-11)
    A1002 Beta-Amyloid (1-11)
    Summary: Amyloidogenic peptide
      insoluble in EtOH; ≥132.5 mg/mL
  4. Amyloid β-Protein (1-15)
    A1003 Amyloid β-Protein (1-15)
    Summary: Principal component of amyloid
      insoluble in EtOH; ≥182.6 mg/mL
  5. Amyloid Precursor C-Terminal Peptide
    A1004 Amyloid Precursor C-Terminal Peptide
    Summary: For beta amyloid generation
      ≥189.6 mg/mL
  6. amyloid A protein fragment [Homo sapiens]
    A1053 amyloid A protein fragment [Homo sapiens]
    Summary: Apolipoproteins related to HDL in plasma
  7. Methoxy-X04
    B5769 Methoxy-X04
    Summary: fluorescent amyloid β (Aβ) probe
      ≥51.9 mg/mL
  8. J 147
    B5804 J 147
    Summary: reduces soluble Aβ40 and Aβ42 levels
      insoluble in H2O; ≥16.65 mg/mL
  9. Amyloid β-Peptide (10-20) (human)
    A1038 Amyloid β-Peptide (10-20) (human)
    Summary: Initiates neurodegeneration in Alzheimer disease
      insoluble in EtOH; ≥144.7 mg/mL
  10. ARN2966
    B8029 ARN2966
    Summary: APP expression modulator
      Soluble in DMSO

Items 1-10 of 26

Page
per page
Relate Categories